Stephens Inc Amphastar Pharmaceuticals, Inc. Transaction History
Stephens Inc
- $6.31 Billion
- Q2 2024
A detailed history of Stephens Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Stephens Inc holds 10,935 shares of AMPH stock, worth $496,667. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,935
Previous 9,139
19.65%
Holding current value
$496,667
Previous $401,000
8.98%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$121 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$88.3 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$76.8 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$73.7 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...